Compare Match Group Inc (MTCH) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Match Group Inc vs Zimmer Biomet Holdings Inc — how do they compare? Match Group Inc trades at $39.02 (market cap $9.10B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Zimmer Biomet Holdings Inc is the larger of the two by market cap, and Match Group Inc pays the higher dividend (2.05%). Which is the better fit depends on your goals.
| MTCH | ZBH | |
|---|---|---|
Market Cap | $9.10B | $17.36B |
Sector | Media | Health |
52-Week High | $40.29 | $107.71 |
52-Week Low | $28.90 | $79.58 |
Enterprise Value | $12.05B | $24.40B |
Dividend Yield | 2.05% | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MTCH trades at $38.75, down 1.02% today, near the analyst low target of $38.00. The stock shows a bullish technical signal with strong moving average support, while oscillators remain neutral. Recent Q1 2026 earnings missed expectations, but Q3 and Q4 2025 beat estimates. Revenue growth is stable at $3.5B annually, with net income margins improving to 17.59% in 2025. Positive news highlights Tinder's turnaround efforts and Hinge's growth, with a dividend scheduled for July 2026.
Outlook is cautiously optimistic with a consensus price target of $41.63, implying ~7% upside. Strengths include high gross margins (73.8%) and consistent cash flow growth. Risks involve high debt ($3.85B) and Tinder's user declines offset by pricing. Analyst sentiment is bullish (53% Buy), but execution on user engagement remains critical for sustained gains.
Zimmer Biomet (ZBH) trades at $88.92, down 2.41% on the day, with a bearish technical signal but strong fundamentals including a 70.03% gross margin and three consecutive quarterly EPS beats. Revenue grew to $8.23B in 2025, though net income margin compressed to 8.56%. The company announced a $1 billion share repurchase increase and expansion in India, while maintaining a dividend.
The stock offers a 10% upside to the $97.67 consensus price target, supported by value metrics and operational strength, but faces risks from rising debt levels and competitive pressures. Analyst sentiment is mixed with 40% buy ratings, suggesting cautious optimism amid near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Match Group Inc
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
